| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |